Company Filing History:
Years Active: 2021-2023
Title: Levon Isakulyan: Innovator in Opioid Therapeutics
Introduction
Levon Isakulyan is a notable inventor based in New York, NY (US), recognized for his contributions to the field of opioid therapeutics. He holds two patents that focus on enhancing the efficacy of opioid-derived compositions and their antagonists. His work aims to improve pain management and sobering processes through innovative modifications.
Latest Patents
Isakulyan's latest patents include "Compositions and methods of use for opioid hexadienoates and optionally substituted hexadienoates." This invention relates to opiate-derived compositions that are useful in therapeutic areas associated with opioid receptor modulation. The patent describes a 3-hexadienoate modification of opioids, which is formulated to enhance the engagement of opioid receptors when administered orally. Additionally, it includes modifications of nalbuphine and naloxone, aimed at improving pain management and sobering quality through various administration routes.
Career Highlights
Levon Isakulyan is currently associated with Kappa-Pharma LLC, where he continues to innovate in the field of pharmaceuticals. His work is pivotal in addressing the challenges associated with opioid use and its therapeutic applications.
Collaborations
Isakulyan collaborates with notable colleagues, including Georgiy Nikonov and Michael Voronkov, who contribute to the research and development efforts at Kappa-Pharma LLC.
Conclusion
Levon Isakulyan's innovative work in opioid therapeutics showcases his commitment to improving pain management and treatment outcomes. His patents reflect a significant advancement in the field, highlighting the importance of ongoing research and development in pharmaceuticals.